Exane Derivatives’s iShares MSCI Emerging Markets ETF EEM Stock Holding History

Exane Derivatives’s Portfolio EEM Stock Details EEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$40	Sell	1 -16,964	-100%	-$712K	﹤0.01%	747
2022 Q1	$766K	Buy	+16,965	New	+$801K	0.22%	125
2020 Q3	–	Sell	-207,670	Closed	-$8.3M	–	761
2020 Q2	$8.3M	Sell	207,670 -26,610	-11%	-$996K	2.22%	6
2020 Q1	$8M	Sell	234,280 -249,835	-52%	-$10.2M	2.23%	7
2019 Q4	$22.1M	Buy	484,115 +226,837	+88%	+$9.74M	4.1%	2
2019 Q3	$10.5M	Sell	257,278 -89,369	-26%	-$3.69M	1.89%	11
2019 Q2	$14.9M	Buy	346,647 +2,148	+0.6%	+$91.2K	2.61%	6
2019 Q1	$14.8M	Sell	344,499 -16,534	-5%	-$696K	2.92%	4
2018 Q4	$14.1M	Sell	361,033 -11,943	-3%	-$478K	2.53%	6
2018 Q3	$16M	Buy	372,976 +77,614	+26%	+$3.35M	3%	4
2018 Q2	$12.8M	Buy	295,362 +48,161	+19%	+$2.23M	2.14%	10
2018 Q1	$11.7M	Sell	247,201 -252,801	-51%	-$12.4M	2.34%	7
2017 Q4	$23.6M	Buy	500,002 +47,424	+10%	+$2.19M	4.06%	6
2017 Q3	$20.3M	Buy	452,578 +145,916	+48%	+$6.42M	3.79%	5
2017 Q2	$12.7M	Buy	306,662 +181,723	+145%	+$7.4M	2.73%	5
2017 Q1	$4.92M	Sell	124,939 -763,585	-86%	-$29M	1.11%	21
2016 Q4	$31.1M	Buy	888,524 +329,934	+59%	+$11.9M	6.14%	2
2016 Q3	$20.9M	Buy	558,590 +248,759	+80%	+$9.09M	3.14%	3
2016 Q2	$10.6M	Sell	309,831 -31,027	-9%	-$1.04M	1.76%	28
2016 Q1	$11.7M	Sell	340,858 -31,185	-8%	-$966K	1.55%	31
2015 Q4	$12M	Buy	372,043 +253,732	+214%	+$8.7M	1.64%	26
2015 Q3	$3.88M	Sell	118,311 -119,117	-50%	-$4.21M	0.49%	48
2015 Q2	$9.41M	Buy	237,428 +174,583	+278%	+$7.3M	1.01%	35
2015 Q1	$2.52M	Buy	+62,845	New	+$2.5M	0.28%	58

Other funds holding EEM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Exane Derivatives's EEM Position: Q2 2022 in Review

Exane Derivatives reduced its iShares MSCI Emerging Markets ETF (EEM) stake by 100% in Q2 2022, selling an estimated $712K and leaving 1 share worth $40. The position accounts for ﹤0.01% of the portfolio, ranked #747.

Exane Derivatives first reported a position in EEM in Q1 2015 and has held it in 24 quarters since. The position peaked at $31.1M in Q4 2016. 1,284 funds tracked by Wall St. Rank hold EEM as of Q2 2022.

Exane Derivatives held 1 share of iShares MSCI Emerging Markets ETF worth $40 as of Q2 2022.
Exane Derivatives sold 16,964 iShares MSCI Emerging Markets ETF shares in Q2 2022, an estimated $712K.
iShares MSCI Emerging Markets ETF made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #747 holding.
Exane Derivatives first reported a position in iShares MSCI Emerging Markets ETF in Q1 2015 and has held it in 24 quarters since.
Exane Derivatives's iShares MSCI Emerging Markets ETF position peaked at $31.1M in Q4 2016.
1,284 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.